Massachusetts S 696: An Act to promote transparency and cost control of pharmaceutical drug prices

Status: Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session (as of 2020-07-23)

State: Massachusetts · Session: 191st · Bill: S 696

Sponsors: Eric P. Lesser, Diana DiZoglio, Eric P. Lesser, José F. Tosado

View Massachusetts S 696 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.